109 related articles for article (PubMed ID: 11366725)
1. Remune trial ended.
Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
[TBL] [Abstract][Full Text] [Related]
2. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
3. Agouron and immune response to commercialize remune immune-based treatment.
James JS
AIDS Treat News; 1998 Jun; (No 297):1. PubMed ID: 11365593
[TBL] [Abstract][Full Text] [Related]
4. Rebuilding immunity with Remune.
Whitfield L
Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
[TBL] [Abstract][Full Text] [Related]
5. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
6. In brief: immune based therapies.
Proj Inf Perspect; 1999 Sep; (28):24. PubMed ID: 11367364
[TBL] [Abstract][Full Text] [Related]
7. Remune trial stopped.
Vazquez E
Posit Aware; 1999; 10(4):29. PubMed ID: 11366802
[TBL] [Abstract][Full Text] [Related]
8. A primer on HIV type 1-specific immune function and REMUNE.
Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
[TBL] [Abstract][Full Text] [Related]
9. Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.
Chantratita W; Sukeepaisarncharoen W; Chandeying V; Kulpradist S; Israngkura Na Ayudhtaya B; Rugpao S; Sirawaraporn W; Boonshuyar C; Churdboonchart V
HIV Med; 2004 Sep; 5(5):317-25. PubMed ID: 15369506
[TBL] [Abstract][Full Text] [Related]
10. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjects.
Moss RB; Li L; Giermakowska WK; Lanza P; Turner JL; Wallace MR; Jensen FC; Richieri SP; Daigle AE; Theofan G; Carlo DJ
J Hum Virol; 1998; 1(2):77-81. PubMed ID: 10195235
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression.
James JS
AIDS Treat News; 1998 Jul; (No 298):1-5. PubMed ID: 11365597
[TBL] [Abstract][Full Text] [Related]
15. Eager Thailand takes on questionable therapies.
Birmingham K
Nat Med; 2002 Aug; 8(8):767-8. PubMed ID: 12152015
[No Abstract] [Full Text] [Related]
16. Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert.
Kim HN; Tabet SR; Corey L; Celum CL
Vaccine; 2006 Jan; 24(4):532-9. PubMed ID: 16242816
[TBL] [Abstract][Full Text] [Related]
17. Trial suggests vaccines could aid HIV therapy.
Check E
Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
[No Abstract] [Full Text] [Related]
18. A tale of two trials of HAART interruption.
STEP Perspect; 1999; 99(1):7. PubMed ID: 11367165
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of HIV treatment begin in Thailand.
AIDS Wkly Plus; 1996 Apr 8-15; ():14. PubMed ID: 12320053
[TBL] [Abstract][Full Text] [Related]
20. Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan Dawson.
Moss R
STEP Perspect; 1998; 98(2):13-6. PubMed ID: 11365540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]